Academic Journal
View in EDS
HTML Full Text

Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate.

Bibliographic Details
Title: Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate.
Authors: Boschheidgen, M., Schimmöller, L., Doerfler, S., Al-Monajjed, R., Morawitz, J., Ziayee, F., Mally, D., Quentin, M., Arsov, C., Albers, P., Antoch, G., Ullrich, T.
Source: Scientific Reports; 4/25/2022, Vol. 12 Issue 1, p1-7, 7p
Subject Terms: PROSTATE biopsy, PROSTATE, MAGNETIC resonance imaging
Abstract: To evaluate if follow-up mpMRI scans of patients in PI-RADS category 3 are safe enough to omit or delay prostate biopsy in the future and to determine an optimal control interval. This retrospective single center study includes consecutive PI-RADS category 3 patients with one or more follow-up mpMRI (T2WI, DWI, DCE) and subsequent MRI-targeted and systematic TRUS-guided biopsy between 2012 and 2018. Primary study objective was the verification of a significant PI-RADS category upgrade in follow-up mpMRI in patients with subsequent PCA positive biopsy versus patients with negative biopsy. Further objectives were development of the PI-RADS category and clinical parameters between initial and follow-up mpMRI in the context of histopathologic results and time interval. Eighty-nine patients (median PSA 6.6 ng/ml; PSAD 0.13 ng/ml/ml) were finally included (follow-up period 31 ± 18 months). 19 cases had PCA (median PSA 7.8 ng/ml; PSAD 0.14 ng/ml/ml). 4 cases had csPCA (median PSA 5.4 ng/ml; PSAD 0.13 ng/ml/ml) for which there was a significant PI-RADS upgrade after 12–24 months (mean 3.75; p = 0.01) compared to patients without PCA (mean 2.74). Without PCA the mean PI-RADS category decreased after 25–36 months (mean 2.74; p = 0.02). Clinical parameters did not change significantly except a PSAD increase for PCA patients after 24 months. Patients within PI-RADS category 3 may not need prompt biopsy since those with PCA reliably demonstrate a PI-RADS category upgrade in follow-up mpMRI after 12–24 months. PI-RADS 3 patients with negative biopsy do not benefit from follow-up mpMRI earlier than 24 months. [ABSTRACT FROM AUTHOR]
Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edb&genre=article&issn=20452322&ISBN=&volume=12&issue=1&date=20220425&spage=1&pages=1-7&title=Scientific Reports&atitle=Single%20center%20analysis%20of%20an%20advisable%20control%20interval%20for%20follow-up%20of%20patients%20with%20PI-RADS%20category%203%20in%20multiparametric%20MRI%20of%20the%20prostate.&aulast=Boschheidgen%2C%20M.&id=DOI:10.1038/s41598-022-10859-9
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
Header DbId: edb
DbLabel: Complementary Index
An: 156499441
RelevancyScore: 938
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 937.573913574219
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Boschheidgen%2C+M%2E%22">Boschheidgen, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Schimmöller%2C+L%2E%22">Schimmöller, L.</searchLink><br /><searchLink fieldCode="AR" term="%22Doerfler%2C+S%2E%22">Doerfler, S.</searchLink><br /><searchLink fieldCode="AR" term="%22Al-Monajjed%2C+R%2E%22">Al-Monajjed, R.</searchLink><br /><searchLink fieldCode="AR" term="%22Morawitz%2C+J%2E%22">Morawitz, J.</searchLink><br /><searchLink fieldCode="AR" term="%22Ziayee%2C+F%2E%22">Ziayee, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Mally%2C+D%2E%22">Mally, D.</searchLink><br /><searchLink fieldCode="AR" term="%22Quentin%2C+M%2E%22">Quentin, M.</searchLink><br /><searchLink fieldCode="AR" term="%22Arsov%2C+C%2E%22">Arsov, C.</searchLink><br /><searchLink fieldCode="AR" term="%22Albers%2C+P%2E%22">Albers, P.</searchLink><br /><searchLink fieldCode="AR" term="%22Antoch%2C+G%2E%22">Antoch, G.</searchLink><br /><searchLink fieldCode="AR" term="%22Ullrich%2C+T%2E%22">Ullrich, T.</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Scientific Reports; 4/25/2022, Vol. 12 Issue 1, p1-7, 7p
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22PROSTATE+biopsy%22">PROSTATE biopsy</searchLink><br /><searchLink fieldCode="DE" term="%22PROSTATE%22">PROSTATE</searchLink><br /><searchLink fieldCode="DE" term="%22MAGNETIC+resonance+imaging%22">MAGNETIC resonance imaging</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: To evaluate if follow-up mpMRI scans of patients in PI-RADS category 3 are safe enough to omit or delay prostate biopsy in the future and to determine an optimal control interval. This retrospective single center study includes consecutive PI-RADS category 3 patients with one or more follow-up mpMRI (T2WI, DWI, DCE) and subsequent MRI-targeted and systematic TRUS-guided biopsy between 2012 and 2018. Primary study objective was the verification of a significant PI-RADS category upgrade in follow-up mpMRI in patients with subsequent PCA positive biopsy versus patients with negative biopsy. Further objectives were development of the PI-RADS category and clinical parameters between initial and follow-up mpMRI in the context of histopathologic results and time interval. Eighty-nine patients (median PSA 6.6 ng/ml; PSAD 0.13 ng/ml/ml) were finally included (follow-up period 31 ± 18 months). 19 cases had PCA (median PSA 7.8 ng/ml; PSAD 0.14 ng/ml/ml). 4 cases had csPCA (median PSA 5.4 ng/ml; PSAD 0.13 ng/ml/ml) for which there was a significant PI-RADS upgrade after 12–24 months (mean 3.75; p = 0.01) compared to patients without PCA (mean 2.74). Without PCA the mean PI-RADS category decreased after 25–36 months (mean 2.74; p = 0.02). Clinical parameters did not change significantly except a PSAD increase for PCA patients after 24 months. Patients within PI-RADS category 3 may not need prompt biopsy since those with PCA reliably demonstrate a PI-RADS category upgrade in follow-up mpMRI after 12–24 months. PI-RADS 3 patients with negative biopsy do not benefit from follow-up mpMRI earlier than 24 months. [ABSTRACT FROM AUTHOR]
– Name: Abstract
  Label:
  Group: Ab
  Data: <i>Copyright of Scientific Reports is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=156499441
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-022-10859-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 7
        StartPage: 1
    Subjects:
      – SubjectFull: PROSTATE biopsy
        Type: general
      – SubjectFull: PROSTATE
        Type: general
      – SubjectFull: MAGNETIC resonance imaging
        Type: general
    Titles:
      – TitleFull: Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boschheidgen, M.
      – PersonEntity:
          Name:
            NameFull: Schimmöller, L.
      – PersonEntity:
          Name:
            NameFull: Doerfler, S.
      – PersonEntity:
          Name:
            NameFull: Al-Monajjed, R.
      – PersonEntity:
          Name:
            NameFull: Morawitz, J.
      – PersonEntity:
          Name:
            NameFull: Ziayee, F.
      – PersonEntity:
          Name:
            NameFull: Mally, D.
      – PersonEntity:
          Name:
            NameFull: Quentin, M.
      – PersonEntity:
          Name:
            NameFull: Arsov, C.
      – PersonEntity:
          Name:
            NameFull: Albers, P.
      – PersonEntity:
          Name:
            NameFull: Antoch, G.
      – PersonEntity:
          Name:
            NameFull: Ullrich, T.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 04
              Text: 4/25/2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 20452322
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific Reports
              Type: main
ResultId 1